Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Sanofi introduces LeGoo gel to temporarily stop blood flow during cardiovascular surgery

Sanofi US announced the commercial launch of LeGoo, a biopolymer gel that allows surgeons to temporarily stop blood flow during surgery without the use of clamps, elastic loops or other conventional occlusion devices, which may increase risk of trauma to blood vessels.

30 Jan 2013

Genzyme receives FDA approval for Kynamro to treat homozygous familial hypercholesterolemia

The U.S. Food and Drug Administration today approved Kynamro (mipomersen sodium) injection as an addition to lipid-lowering medications and diet to treat patients with a rare type of high cholesterol called homozygous familial hypercholesterolemia (HoFH).

30 Jan 2013

Have scientists thoroughly addressed avian flu research concerns?

Noting that a nearly yearlong moratorium on H5N1 avian influenza research, put in place "because of safety and terrorism concerns," was lifted recently, a New York Times editorial states, "We wish we could be as sanguine as they are that all the earlier concerns have been dealt with."

29 Jan 2013

Study examines how fear responses are learned, controlled and memorized

A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.

29 Jan 2013

New tweet-screening method effectively tracks flu cases

Sifting through social media messages has become a popular way to track when and where flu cases occur, but a key hurdle hampers the process: how to identify flu-infection tweets. Some tweets are posted by people who have been sick with the virus, while others come from folks who are merely talking about the illness. If you are tracking actual flu cases, such conversations about the flu in general can skew the results.

29 Jan 2013

Common myths about flu from Mayo Clinic

It seems you can't go anywhere these days without hearing "the flu this" or "the flu that." Unfortunately, this season's influenza outbreak is one of the worst in years. And it's not just the flu virus that's causing problems; there are also many myths about the flu that are keeping people from doing more to prevent it.

29 Jan 2013

1 in 5 people infected with swine flu during first year of epidemic, WHO-led study shows

"At least one in five people worldwide were infected with swine flu during the first year of the 2009-2010 H1N1 pandemic, an international research group said on Friday, but the death rate was just 0.02 percent," Reuters reports.

29 Jan 2013

New research sets out alternative approach to pandemic preparedness

'Evil' scientists, deadly viruses and terrorist plots are usually the preserve of Hollywood blockbusters. But when it comes to pandemic influenza, it is the stuff of real life. As controversy about research into the H5N1 bird flu virus continues, a new paper argues for a complete overhaul of current approaches to pandemic preparedness.

29 Jan 2013

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.

28 Jan 2013

Positive top-line results from Biogen Idec’s peginterferon beta-1a Phase 3 trial on RRMS

Today Biogen Idec released the primary efficacy analysis and safety data from its Phase 3 pivotal clinical trial, ADVANCE.

28 Jan 2013

FDA accepts Genzyme’s LEMTRADA sBLA for review

Genzyme, a Sanofi Company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental Biologics License Application (sBLA) file seeking approval of LEMTRADA (alemtuzumab) for the treatment of relapsing multiple sclerosis (RMS).

28 Jan 2013

FDA approves Pfizer’s Prevnar 13 to prevent pneumococcal disease in older children, adolescents

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the expansion of the company's pneumococcal conjugate vaccine, Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for use in older children and adolescents aged 6 years through 17 years for active immunization for the prevention of invasive disease caused by the 13 Streptococcus pneumoniae serotypes contained in the vaccine.

28 Jan 2013

Antibiotic use common at the end of life

More than one-quarter of hospice patients receive antibiotics in their last week of life, despite the absence of documented infection in most cases, US researchers report.

25 Jan 2013

High vaccine prices ignored by ‘Decade of Vaccines’ blueprint

Governments meeting at the World Health Organization’s Executive Board (WHO EB) this week must seize the opportunity to improve serious shortcomings in the document that will drive the global community’s vaccines response in the next few years. If they fail to do so, key reasons why children continue to be missed by immunisation programmes will be left unaddressed.

25 Jan 2013

Voluntary moratorium on H5N1 research ends; fate of U.S.-funded research unknown

"Almost a year after they announced it, leading influenza researchers are ending a voluntary moratorium on certain types of controversial experiments involving the H5N1 avian influenza virus."

25 Jan 2013

Study into H1N1 pandemic suggests at least 1 in 5 were infected

At least one in five people in countries for which data are available were infected with influenza during the first year of the 2009 H1N1 pandemic, according to a new study.

25 Jan 2013

Skin care tips for winter season

Our bodies have a natural layer of oil that helps protect the skin, but the dry air of winter (along with poor skin care) can override this natural protection and leave a lot of people with itchy, scaly winter skin.

25 Jan 2013

AACN expands its hospital-based nurse leadership and innovation training program

The American Association of Critical-Care Nurses (AACN) expands its hospital-based nurse leadership and innovation training program to a fourth region with the addition of eight Austin-area hospitals.

25 Jan 2013

Ibuprofen and naproxen can cause kidney damage in children

Sick children, especially those with some dehydration from flu or other illnesses, risk significant kidney injury if given drugs such as ibuprofen and naproxen, Indiana University School of Medicine researchers said Friday.

25 Jan 2013

Neuromuscular blockade (NMB) reversal

General anesthesia is made up of three components: hypnotic medicines, to induce sleep; analgesics, or medicines to inhibit pain; and NMB agents that induce muscle relaxation. Anesthesiology professionals use NMB to relax a patient’s muscles and prevent involuntary movement that could impact surgery.

24 Jan 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Sanofi introduces LeGoo gel to temporarily stop blood flow during cardiovascular surgery

Genzyme receives FDA approval for Kynamro to treat homozygous familial hypercholesterolemia

Have scientists thoroughly addressed avian flu research concerns?

Study examines how fear responses are learned, controlled and memorized

New tweet-screening method effectively tracks flu cases

Common myths about flu from Mayo Clinic

1 in 5 people infected with swine flu during first year of epidemic, WHO-led study shows

New research sets out alternative approach to pandemic preparedness

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Positive top-line results from Biogen Idec’s peginterferon beta-1a Phase 3 trial on RRMS

FDA accepts Genzyme’s LEMTRADA sBLA for review

FDA approves Pfizer’s Prevnar 13 to prevent pneumococcal disease in older children, adolescents

Antibiotic use common at the end of life

High vaccine prices ignored by ‘Decade of Vaccines’ blueprint

Voluntary moratorium on H5N1 research ends; fate of U.S.-funded research unknown

Study into H1N1 pandemic suggests at least 1 in 5 were infected

Skin care tips for winter season

AACN expands its hospital-based nurse leadership and innovation training program

Ibuprofen and naproxen can cause kidney damage in children

Neuromuscular blockade (NMB) reversal

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in